TP53 and cancer: By analyzing p53 wild type‐SCC of the cervix, anal canal, oropharynx, and vulva, we sought to determine whether different HPV‐positive cancers may respond to common treatment protocols and to identify targetable alterations for patients with these cancers that are advanced, refractory, and difficult to treat.